Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins? — Giancarlo Agnelli (1995) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
Shared by
Giancarlo Agnelli
University of Perugia
Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
Article
1995
Related publications
Article
2001
Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes
Kirk Magee
,
Brian Rowe
,
David Moher
,
William W Sevcik
Article
2003
Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes
Kirk Magee
,
William W Sevcik
,
David Moher
,
en
Authors
Giancarlo Agnelli
University Of Perugia
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Brian H. Rowe
Article
2008
Prevention of venous thromboembolism after acute spinal cord injury with low-dose heparin or low-molecular-weight heparin
Walter Ageno
,
Giancarlo Agnelli
,
Maurizio Paciaroni
Article
2022
Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in Spain
Andrés J. Muñoz Martín
,
Enrique Gallardo
,
Giancarlo Agnelli
,
Carlos Crespo
,
Monica Forghani
,
Daniel Arumí
,
Susana Fernández de Cabo
,
Javier Soto
Article
1990
Clinical experience with low molecular weight heparins
Giuseppe G. Nenci
,
Giancarlo Agnelli
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.